Organ-Specific In Vitro Research
Single organ in vitro research is used to identify adverse outcome pathways (AOPs) and targets of toxicity. Identifying AOPs and targets of toxicity is a critical component to understanding overall chemical hazard and for performing risk assessment.
Many of the in vitro screens offered by IONTOX and used industry wide were pioneered by IONTOX founder James Mckim,P.h.D, D.A.B.T. 15 years ago. IONTOX continues this trend of innovation by finding and developing the latest in vitro testing methods and putting them to work for your business.
Many of the in vitro screens offered by IONTOX and used industry wide were pioneered by IONTOX founder James Mckim,P.h.D, D.A.B.T. 15 years ago. IONTOX continues this trend of innovation by finding and developing the latest in vitro testing methods and putting them to work for your business.
IONTOX In Vitro Single Organ Testing Capabilities
- Ocular Irritation
- ET 50 (Potency)
- Dermal Corrosion
- Dermal Irritation
- ET-50(Potency)
- Compound Permeability/ Absorption
- Metabolism
- Inflammation
- General Toxicity
- Inflammation
- Metabolism
- General Toxicity
- IDILI Liability
- General Renal Toxicity
- Drug Drug Interaction (DDI)
- General Toxicity
Work with IONTOX
Click the button below and fill out the form on the following page to contact IONTOX about your in vitro study.